Exelixis Inc Adjustments to Additional Paid in Capital, Warrant Issued
Exelixis Inc (EXEL) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.47 million for the 12-month period ending 2016-01-01, per its 10-K filed 2018-02-26.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2018-02-26
- Exelixis Inc adjustments to additional paid in capital, warrant issued for fiscal 2016 was $1.47M.
- Exelixis Inc adjustments to additional paid in capital, warrant issued for fiscal 2015 was $1.47M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|
| 2016-01-01 | $1.47M 10-K · filed 2018-02-26 |
| 2015-12-31 | $1.47M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |